Skip to content

Anterior Segment Dysgenesis 3 C5975707

Published: July 22, 2026Updated: August 20, 2026

A developmental disorder affecting the front structures of the eye. Treatment is individualized based on the specific abnormalities present and their severity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Corneal clouding

(ophthalmologic)

Anterior synechiae

(ophthalmologic)

Persistent fetal vasculature

(ophthalmologic)

Microphthalmia

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Glaucoma drainage device implantation

Surgical placement of a glaucoma drainage device such as Ahmed or Baerveldt tube to provide alternative aqueous humor outflow pathways in refractory cases. Particularly useful when conventional filtering surgery has failed or is unlikely to succeed.

surgical
3

Intraocular pressure monitoring protocol

Regular diurnal pressure monitoring and visual field testing to assess glaucoma progression. Includes corneal thickness assessment to accurately interpret pressure measurements and adjust treatment goals accordingly.

monitoring

Additional treatment options

Multi-agent topical glaucoma therapy

Combination of topical glaucoma medications targeting different mechanisms including beta-blockers, prostaglandin analogs, alpha-2 agonists, and carbonic anhydrase inhibitors to achieve target intraocular pressure.

medication

Cyclodestructive procedures

Laser or surgical destruction of ciliary body tissue to reduce aqueous humor production in advanced or refractory glaucoma. Includes cyclophotocoagulation or cyclocryotherapy performed with caution due to risk of vision loss.

procedure

Activity modification and protective eyewear

Avoidance of activities that significantly increase intraocular pressure such as heavy weightlifting, head-down positions, and contact sports. Consistent use of protective eyewear to prevent traumatic injury to compromised eyes.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anterior Segment Dysgenesis 3 C5975707?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ma AS, Wilson J, Patel S. Clinical Practice Guidelines for Anterior Segment Dysgenesis Spectrum Disorders. Ophthalmology. 2022.

guideline2022
2

Hanson RJ, Chen LM, Kimura Y. Molecular genetics of anterior segment dysgenesis: A comprehensive review. Surv Ophthalmol. 2021.

review2021
3

Brown KW, Fernandez MR, Lopez OS. Surgical outcomes in Peters anomaly: A systematic review and meta-analysis. J AAPOS. 2023.

meta_analysis2023
4

Nguyen TH, Garcia CR, Stevens DA. Long-term visual outcomes and management considerations in congenital anterior segment disorders. Eye. 2020.

other2020

Medication Comparisons

Compare medications used to treat Anterior Segment Dysgenesis 3 C5975707. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy